Search

Pages

1. • Journal article

   • 

   Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.

   Perrot, Aurore Lauwers-Cances, Valerie Corre, Jill Robillard, Nelly Hulin, Cyrille Chretien, Marie-Lorraine Dejoie, Thomas Maheo, Sabrina Stoppa, Anne-Marie Pegourie, Brigitte Karlin, Lionel Garderet, Laurent Arnulf, Bertrand Doyen, Chantal[UCL] Meuleman, Nathalie Royer, Bruno Eveillard, Jean-Richard Benboubker, Lotfi Dib, Mamoun Decaux, Olivier Jaccard, Arnaud Belhadj, Karim Brechignac, Sabine Kolb, Brigitte Fohrer, Cecile Mohty, Mohamad Macro, Margaret Richardson, Paul G Carlton, Victoria Moorhead, Martin Willis, Tom Faham, Malek Anderson, Kenneth C Harousseau, Jean-Luc Leleu, Xavier Facon, Thierry Moreau, Philippe Attal, Michel Avet-Loiseau, Hervé Munshi, Nikhil (2018) Blood — Vol. 132, no. 23, p. 2456-2464 (2018)
2. • Journal article

   • 

   Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires

   Brice, Pauline Bastion, Yves Lepage, Eric Brousse, Nicole Haïoun, Corinne Moreau, Philippe[USL-B] Straetmans, Nicole[UCL] Tilly, Hervé Tabah, Isabelle Solal-Céligny, Philippe (1997) Journal of Clinical Oncology — Vol. 15, no.3, p. 1110-1117 (1997)
3. • Journal article

   • 

   Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.

   Yakoub-Agha, Ibrahim Mary, Jean-Yves Hulin, Cyrille Doyen, Chantal Marit, Gérald Benboubker, Lotfi Voillat, Laurent Moreau, Philippe Berthou, Christian Stoppa, Anne-Marie Maloisel, Frédéric Rodon, Philippe Dib, Mamoun Pegourie, Brigitte Casassus, Philippe Slama, Borhane Damaj, Ghandi Zerbib, Robert Harousseau, Jean-Luc Mohty, Mohamad Facon, Thierry (2012) European journal of haematology — Vol. 88, no.3, p. 249-59 (2012)
4. • Journal article

   • 

   Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUSTM (MM-010): a phase 3b study in refractory multiple myeloma.

   Dimopoulos, Meletios A Palumbo, Antonio Corradini, Paolo Cavo, Michele Delforge, Michel Di Raimondo, Francesco Weisel, Katja C Oriol, Albert Hansson, Markus Vacca, Angelo Blanchard, Maria Jesus Goldschmidt, Hartmut Doyen, Chantal[UCL] Kaiser, Martin Petrini, Mario Anttila, Pekka Cafro, Anna Maria Raymakers, Reinier San Miguel, Jesus de Arriba, Felipe Knop, Stefan Röllig, Christoph Ocio, Enrique M Morgan, Gareth Miller, Neil Simcock, Mathew Peluso, Teresa Herring, Jennifer Sternas, Lars Zaki, Mohamed Moreau, Philippe (2016) Blood — Vol. 128, no. 4, p. 497-503 (2016)
5. • Journal article

   • 

   Lenalidomide maintenance after stem-cell transplantation for multiple myeloma

   Attal, Michel Lauwers-Cances, Valerie Marit, Gerald Caillot, Denis Moreau, Philippe Facon, Thierry Stoppa, Anne Marie Hulin, Cyrille Benboubker, Lofti Garderet, Laurent Decaux, Olivier Leyvraz, Serge Vekemans, Marie-Christiane[UCL] Voillat, Laurent Michallet, Mauricette Pegourie, Brigitte Dumontet, Charles Roussel, Murielle Leleu, Xavier Mathiot, Claire Payen, Catherine Avet-Loiseau, Hervé Harousseau, Jean-Luc IFM Investigators Van Den Neste, Eric[UCL] (2012) New England Journal of Medicine — Vol. 366, no.19, p. 1782-1791 (2012)
6. • Journal article

   • 

   Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.

   Moreau, Philippe Attal, Michel Hulin, Cyrille Arnulf, Bertrand Belhadj, Karim Benboubker, Lotfi Béné, Marie C Broijl, Annemiek Caillon, Hélène Caillot, Denis Corre, Jill Delforge, Michel Dejoie, Thomas Doyen, Chantal[UCL] Facon, Thierry Sonntag, Cécile Fontan, Jean Garderet, Laurent Jie, Kon-Siong Karlin, Lionel Kuhnowski, Frédérique Lambert, Jérôme Leleu, Xavier Lenain, Pascal Macro, Margaret Mathiot, Claire Orsini-Piocelle, Frédérique Perrot, Aurore Stoppa, Anne-Marie van de Donk, Niels Wcj Wuilleme, Soraya Zweegman, Sonja Kolb, Brigitte Touzeau, Cyrille Roussel, Murielle Tiab, Mourad Marolleau, Jean-Pierre Meuleman, Nathalie Vekemans, Marie-Christiane[UCL] Westerman, Matthijs Klein, Saskia K Levin, Mark-David Fermand, Jean Paul Escoffre-Barbe, Martine Eveillard, Jean-Richard Garidi, Reda Ahmadi, Tahamtan Zhuang, Sen Chiu, Christopher Pei, Lixia de Boer, Carla Smith, Elena Deraedt, William Kampfenkel, Tobias Schecter, Jordan Vermeulen, Jessica Avet-Loiseau, Hervé Sonneveld, Pieter (2019) Lancet — Vol. 394, no. 10192, p. 29-38 (2019)
7. • Journal article

   • 

   Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial.

   Moreau, Philippe Attal, Michel Pégourié, Brigitte Planche, Lucie Hulin, Cyrille Facon, Thierry Stoppa, Anne-Marie Fuzibet, Jean-Gabriel Grosbois, Bernard Doyen, Chantal Ketterer, Nicolas Sebban, Catherine Kolb, Brigitte Chaleteix, Carine Dib, Mamoun Voillat, Laurent Fontan, Jean Garderet, Laurent Jaubert, Jérôme Mathiot, Claire Esseltine, Dixie Avet-Loiseau, Hervé Harousseau, Jean-Luc (2011) Blood — Vol. 117, no.11, p. 3041-4 (2011)
8. • Journal article

   • 

   Serum free light chains should be the target of response evaluation in light chain multiple myeloma rather than urines.

   Dejoie, Thomas Corre, Jill Caillon, Helene Hulin, Cyrille Perrot, Aurore Caillot, Denis Boyle, Eileen Chretien, Marie-Lorraine Fontan, Jean Belhadj, Karim Brechignac, Sabine Decaux, Olivier Voillat, Laurent Rodon, Philippe Fitoussi, Olivier Araujo, Carla Benboubker, Lotfi Fontan, Charlotte Tiab, Mourad Godmer, Pascal Luycx, Odile Allangba, Olivier Pignon, Jean-Michel Fuzibet, Jean-Gabriel Legros, Laurence Stoppa, Anne-Marie Dib, Mamoun Pegourie, Brigitte Orsini-Piocelle, Frederique Karlin, Lionel Arnulf, Bertrand Roussel, Murielle Garderet, Laurent Mohty, Mohamad Meuleman, Nathalie Doyen, Chantal[UCL] Lenain, Pascal Macro, Margaret Leleu, Xavier Facon, Thierry Moreau, Philippe Attal, Michel Avet-Loiseau, Herve (2016) Blood — Vol. 128, no. 25, p. 1941-2948 (2016)
9. • Journal article

   • 

   Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial

   Moreau, Philippe Hulin, Cyrille Perrot, Aurore Arnulf, Bertrand Belhadj, Karim Benboubker, Lotfi Béné, Marie C Zweegman, Sonja Caillon, Hélène Caillot, Denis Corre, Jill Delforge, Michel Dejoie, Thomas Doyen, Chantal[UCL] Facon, Thierry Sonntag, Cécile Fontan, Jean Mohty, Mohamad Jie, Kon-Siong Karlin, Lionel Kuhnowski, Frédérique Lambert, Jérôme Leleu, Xavier Macro, Margaret Orsini-Piocelle, Frédérique Roussel, Murielle Stoppa, Anne-Marie van de Donk, Niels W C J Wuillème, Soraya Broijl, Annemiek Touzeau, Cyrille Tiab, Mourad Marolleau, Jean-Pierre Meuleman, Nathalie Vekemans, Marie-Christiane[UCL] Westerman, Matthijs Klein, Saskia K Levin, Mark-David Offner, Fritz Escoffre-Barbe, Martine Eveillard, Jean-Richard Garidi, Réda Ahmadi, Tahamtan Krevvata, Maria Zhang, Ke de Boer, Carla Vara, Sanjay Kampfenkel, Tobias Vanquickelberghe, Veronique Vermeulen, Jessica Avet-Loiseau, Hervé Sonneveld, Pieter (2021) The Lancet. Oncology — Vol. 22, no. 10, p. 1378-1390 (2021)
10. • Journal article

    • 

    Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.

    Harousseau, Jean-Luc Avet-Loiseau, Herve Attal, Michel Charbonnel, Catherine Garban, Frederic Hulin, Cyrille Michallet, Mauricette Facon, Thierry Garderet, Laurent Marit, Gerald Ketterer, Nicolas Lamy, Thierry Voillat, Laurent Guilhot, Francois Doyen, Chantal Mathiot, Claire Moreau, Philippe (2009) Journal of clinical oncology : official journal of the American Society of Clinical Oncology — Vol. 27, no.34, p. 5720-6 (2009)
11. • Journal article

    • 

    Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.

    Moreau, Philippe Masszi, Tamás Grzasko, Norbert Bahlis, Nizar J Hansson, Markus Pour, Ludek Sandhu, Irwindeep Ganly, Peter Baker, Bartrum W Jackson, Sharon R Stoppa, Anne-Marie Simpson, David R Gimsing, Peter Palumbo, Antonio Garderet, Laurent Cavo, Michele Kumar, Shaji Touzeau, Cyrille Buadi, Francis K Laubach, Jacob P Berg, Deborah T Lin, Jianchang Di Bacco, Alessandra Hui, Ai-Min van de Velde, Helgi Richardson, Paul G TOURMALINE-MM1 Study Group[UCL] (2016) New England Journal of Medicine — Vol. 374, no.17, p. 1621-1634 (2016)
12. • Journal article

    • 

    Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

    Pertesi, Maroulio Vallée, Maxime Wei, Xiaomu Revuelta, Maria V Galia, Perrine Demangel, Delphine Oliver, Javier Foll, Matthieu Chen, Siwei Perrial, Emeline Garderet, Laurent Corre, Jill Leleu, Xavier Boyle, Eileen M Decaux, Olivier Rodon, Philippe Kolb, Brigitte Slama, Borhane Mineur, Philippe Voog, Eric Le Bris, Catherine Fontan, Jean Maigre, Michel Beaumont, Marie Azais, Isabelle Sobol, Hagay Vignon, Marguerite Royer, Bruno Perrot, Aurore Fuzibet, Jean-Gabriel Dorvaux, Véronique Anglaret, Bruno Cony-Makhoul, Pascale Berthou, Christian Desquesnes, Florence[UCL] Pegourie, Brigitte Leyvraz, Serge Mosser, Laurent Frenkiel, Nicole Augeul-Meunier, Karine Leduc, Isabelle Leyronnas, Cécile Voillat, Laurent Casassus, Philippe Mathiot, Claire Cheron, Nathalie Paubelle, Etienne Moreau, Philippe Bignon, Yves-Jean Joly, Bertrand Bourquard, Pascal Caillot, Denis Naman, Hervé Rigaudeau, Sophie Marit, Gérald Macro, Margaret Lambrecht, Isabelle Cliquennois, Manuel Vincent, Laure Helias, Philippe Avet-Loiseau, Hervé Moreno, Victor Reis, Rui Manuel Varkonyi, Judit Kruszewski, Marcin Vangsted, Annette Juul Jurczyszyn, Artur Zaucha, Jan Maciej Sainz, Juan Krawczyk-Kulis, Malgorzata Wątek, Marzena Pelosini, Matteo Iskierka-Jażdżewska, Elzbieta Grząśko, Norbert Martinez-Lopez, Joaquin Jerez, Andrés Campa, Daniele Buda, Gabriele Lesueur, Fabienne Dudziński, Marek García-Sanz, Ramón Nagler, Arnon Rymko, Marcin Jamroziak, Krzysztof Butrym, Aleksandra Canzian, Federico Obazee, Ofure Nilsson, Björn Klein, Robert J Lipkin, Steven M McKay, James D Dumontet, Charles (2019) Leukemia — Vol. 33, no. 9, p. 2324-2330 (2019)
13. • Journal article

    • 

    Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.

    Chari, Ajai Vogl, Dan T Gavriatopoulou, Maria Nooka, Ajay K Yee, Andrew J Huff, Carol A Moreau, Philippe Dingli, David Cole, Craig Lonial, Sagar Dimopoulos, Meletios Stewart, A Keith Richter, Joshua Vij, Ravi Tuchman, Sascha Raab, Marc S Weisel, Katja C Delforge, Michel Cornell, Robert F Kaminetzky, David Hoffman, James E Costa, Luciano J Parker, Terri L Levy, Moshe Schreder, Martin Meuleman, Nathalie Frenzel, Laurent Mohty, Mohamad Choquet, Sylvain Schiller, Gary Comenzo, Raymond L Engelhardt, Monika Illmer, Thomas Vlummens, Philip Doyen, Chantal[UCL] Facon, Thierry Karlin, Lionel Perrot, Aurore Podar, Klaus Kauffman, Michael G Shacham, Sharon Li, Lingling Tang, Shijie Picklesimer, Carla Saint-Martin, Jean-Richard Crochiere, Marsha Chang, Hua Parekh, Samir Landesman, Yosef Shah, Jatin Richardson, Paul G Jagannath, Sundar (2019) The New England journal of medicine — Vol. 381, no. 8, p. 727-738 (2019)
14. • Journal article

    • 

    Bortezomib and high-dose melphalan conditioning regimen in frontline multiple myeloma: an IFM randomized phase 3 study.

    Roussel, Murielle Lauwers-Cances, Valérie Macro, Margaret Leleu, Xavier Royer, Bruno Hulin, Cyrille Karlin, Lionel Perrot, Aurore Touzeau, Cyrille Chrétien, Marie-Lorraine Rigaudeau, Sophie Dib, Mamoun Nicolas-Virelizier, Emmanuelle Escoffre-Barbe, Martine Belhadj, Karim Mariette, Clara Stoppa, Anne-Marie Araujo, Carla Doyen, Chantal[UCL] Fontan, Jean Kolb, Brigitte Garderet, Laurent Brechignac, Sabine Malfuson, Jean-Valère Jaccard, Arnaud Lenain, Pascal Borel, Cécile Hebraud, Benjamin Benbrahim, Omar Dorvaux, Véronique Manier, Salomon Augeul-Meunier, Karine Vekemans, Marie-Christiane[UCL] Randriamalala, Edouard Chaoui, Driss Caers, Jo Chaleteix, Carine Benboubker, Lofti Vincent, Laure Glaisner, Sylvie Zunic, Patricia Slama, Borhane Eveillard, Jean-Richard Humbrecht-Kraut, Catherine Morel, Véronique Mineur, Philippe Eisenmann, Jean-Claude Demarquette, Hélène Richez, Valentine Vignon, Marguerite Caillot, Denis Facon, Thierry Moreau, Philippe Colin, Anne-Laurène Olivier, Pascale Wuilleme, Soraya Avet-Loiseau, Hervé Corre, Jill Attal, Michel (2022) Blood — Vol. 139, no. 18, p. 2747-2757 (2022)
15. • Journal article

    • 

    Maintenance, therapy with thalidomide improves survival in patients with multiple myeloma

    Attal, Michel Harousseau, Jean-Luc Leyvraz, Serge Doyen, Chantal Hulin, Cyrille Benboubker, Lofti Agha, Ibrahim Yakoub Bourhis, Jean-Henri Garderet, Laurent Pegourie, Brigitte Dumontet, Charles Renaud, Marc Voillat, Laurent Berthou, Christian Marit, Gerald Monconduit, Mathieu Caillot, Denis Grobois, Bernard Avet-Loiseau, Herve Moreau, Philippe Facon, Thierry (2006) Blood — Vol. 108, no. 10, p. 3289-3294 (2006)
16. • Journal article

    • 

    Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.

    Dimopoulos, Meletios A Moreau, Philippe Palumbo, Antonio Joshua, Douglas Pour, Ludek Hájek, Roman Facon, Thierry Ludwig, Heinz Oriol, Albert Goldschmidt, Hartmut Rosiñol, Laura Straub, Jan Suvorov, Aleksandr Araujo, Carla Rimashevskaya, Elena Pika, Tomas Gaidano, Gianluca Weisel, Katja Goranova-Marinova, Vesselina Schwarer, Anthony Minuk, Leonard Masszi, Tamás Karamanesht, Ievgenii Offidani, Massimo Hungria, Vania Spencer, Andrew Orlowski, Robert Z Gillenwater, Heidi H Mohamed, Nehal Feng, Shibao Chng, Wee-Joo ENDEAVOR Investigators[UCL] Vekemans, Marie-Christiane[UCL] Doyen, Chantal[UCL] (2016) The Lancet Oncology — Vol. 17, no. 1, p. 27-38 (2016)
17. • Journal article

    • 

    The EHA Research Roadmap: Malignant Lymphoid Diseases.

    Dreyling, Martin André, Marc[UCL] Gökbuget, Nicola Tilly, Hervé Jerkeman, Mats Gribben, John Ferreri, Andrés Morel, Pierre Stilgenbauer, Stephan Fox, Christopher Maria Ribera, José Zweegman, Sonja Aurer, Igor Bödör, Csaba Burkhardt, Birgit Buske, Christian Dollores Caballero, Maria Campo, Elias Chapuy, Bjoern Davies, Andrew de Leval, Laurence Doorduijn, Jeanette Federico, Massimo Gaulard, Philippe Gay, Francesca Ghia, Paolo Grønbæk, Kirsten Goldschmidt, Hartmut Kersten, Marie-Jose Kiesewetter, Barbara Landman-Parker, Judith Le Gouill, Steven Lenz, Georg Leppä, Sirpa Lopez-Guillermo, Armando Macintyre, Elizabeth Mantega, Maria Victoria Mateos Moreau, Philippe Moreno, Carol Nadel, Bertrand Okosun, Jessica Owen, Roger Pospisilova, Sarka Pott, Christiane Robak, Tadeusz Spina, Michelle Stamatopoulos, Kostas Stary, Jan Tarte, Karin Tedeschi, Allessandra Thieblemont, Catherine Trappe, Ralf Ulrich Trümper, Lorenz H Salles, Gilles (2022) HemaSphere — Vol. 6, no. 6, p. e726 [1-18] (2022)
18. • Journal article

    • 

    Report of the 6th International Workshop on PET in lymphoma.

    Nanni, Cristina Cottereau, Anne Ségolène Lopci, Egesta Bodet-Milin, Caroline Coronado, Monica Pro, Barbara Kim, Wong Seog Trotman, Judith Barrington, Sally Duhrsen, Ulrich Vander Borght, Thierry[UCL] Zamagni, Elena Kraeber-Bodéré, Françoise Messiou, Christina Rahmouni, Alain Buvat, Irène André, Marc[UCL] Hertzberg, Mark Oyen, Wim Casasnovas, Olivier Luminari, Stefano Garderet, Laurent Montravers, Françoise Kobe, Carsten Kluge, Regine Versari, Annibale Zucca, Emanuele Moreau, Philippe Cheson, Bruce Haioun, Corinne Gallamini, Andrea Meignan, Michel (2017) Leukemia and Lymphoma — Vol. 58, no. 10, p. 2298-2303 (2017)
19. • Speech

    • 

    Osteonecrosis of the jaw in multiple myeloma patients (the IFM registry)

    Fuzibet, Jean Gabriel Viellard, Marie Helene Rossignol, Benoit B. R. Doyen, Chantal Hulin, Cyril Garderet, Laurent L. G. Blanc, Michel M. B. Marit, Gerald Facon, Thierry T. F. Moreau, Philippe (2007) 49th Annual Meeting of the American-Society-of-Hematology — Atlanta(Ga)
20. • Speech

    • 

    Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial

    Hulin, Cyrille Facon, Thierry Rodon, Philippe Pegourie, Brigitte Benboubker, Lotfi Doyen, Chantal Dib, Mamoun Guillerm, Gaelle Salles, Bruno Eschard, Jean-Paul Lenain, Pascal Casassus, Philippe Azais, Isabelle Decaux, Olivier Garderet, Laurent Mathiot, Claire Fontan, Jean Lafon, Ingrid Virion, Jean Marc Moreau, Philippe (2009) 49th Annual Meeting of the American-Society-of-Hematology — Atlanta(Ga)
21. • Journal article

    • 

    Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation:

    Garderet, Laurent Iacobelli, Simona Moreau, Philippe Dib, Mamoun Lafon, Ingrid Niederwieser, Dietger Masszi, Tamas Fontan, Jean Michallet, Mauricette Gratwohl, Alois Milone, Giuseppe Doyen, Chantal Pegourie, Brigitte Hajek, Roman Casassus, Philippe Kolb, Brigitte Chaleteix, Carine Hertenstein, Bernd Onida, Francesco Ludwig, Heinz Ketterer, Nicolas Koenecke, Christian van Os, Marleen Mohty, Mohamad Cakana, Andrew Gorin, Norbert Claude de Witte, Theo Harousseau, Jean Luc Morris, Curly Gahrton, Gösta (2012) Journal of Clinical Oncology — Vol. 30, no.20, p. 2475-82 (2012)
22. • Speech

    • 

    Long-Term Follow-up Results of IFM9903 and IFM9904 Trials Comparing Non Myeloablative Allotransplantation with Autologous Transplantation in High-Risk De Novo Multiple Myeloma.

    Moreau, Philippe Garban, Frederic Attal, Michel Michallet, Mauricette Marit, Gerald Hulin, Cyrille Benboubker, Lotfi Doyen, Chantal Mohty, Mohamad Yakoub-Agha, Ibrahim Leyvraz, Serge Casassus, Philippe Avet-Loiseau, Herve Garderet, Laurent Mathiot, Claire Harousseau, Jean-Luc (2008) 50th Annual Meeting of the American- Society-of-Hematology — San Francisco(Ca)
23. • Journal article

    • 

    Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma.

    Moreau, Philippe Avet-Loiseau, Herve Facon, Thierry Attal, Michel Tiab, Mourad Hulin, Cyrille Doyen, Chantal (2011) Blood — Vol. 118, no. 22, p. 5752-5758; quiz 5982 (2011)
24. • Journal article

    • 

    Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial.

    Boyle, Eileen M Leleu, Xavier Petillon, Marie-Odile Karlin, Lionel Doyen, Chantal[UCL] Demarquette, Hélène Royer, Bruno Macro, Margaret Moreau, Philippe Fostier, Karel Marie-Lorraine, Chretien Zarnitsky, Charles Perrot, Aurore Herbaux, Charles Poulain, Stephanie Manier, Salomon Beauvais, David Walker, Brian A Wardell, Christopher P Vincent, Laure Frenzel, Laurent Caillon, Hélène Susanna, Schraen Dejoie, Thomas Avet-Loiseau, Hervé Mohty, Mohamad Facon, Thierry IFM2014-04 investigators (2019) British journal of haematology — Vol. 187, no. 3, p. 319-327 (2019)
25. • Book

    • 

    Le français m’a tuer 

    Hambursin, Olivier[USL-B] Didier, Jean-Jacques Moreau, Philippe Seron, Michel (2006)

Pages